Stem Cell Umbilical Cord Blood (UCB) Market - Company Profile (Cytori Therapeutics Inc.,Advanced Cell Technology, Inc. (USA),California Stem Cell,SWOT Analysis of California Stem Cell,Osiris Therapeutics,NeoStem Inc.,Geron Corporation,Opexa Therapeutics, Inc.,Athersys, Inc.,Pluristem Therapeutics Inc.,Mesoblast Limited)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1 Cytori Therapeutics Inc.

1.1.1 Company Overview

1.1.2 Company Snapshot

1.1.3 Key Financials of Cytori Therapeutics Inc.

1.1.4 Key Strategies of Cytori Therapeutics Inc.

1.1.4.1 Primary Strategies: Approval

1.1.4.2 Secondary Strategies: Product Launch and Clinical trials

1.1.5 SWOT AnalysisofCytori Therapeutics Inc.

1.2 Advanced Cell Technology, Inc. (USA)

1.2.1 Company Overview

1.2.2 Company Snapshot

1.2.3 Key Financials Advanced Cell Technology, Inc. (USA)

1.2.4 Key Strategies Advanced Cell Technology, Inc. (USA)

1.2.4.1 Primary Strategies: Approval

1.2.4.2 Secondary strategies: Study Report

1.2.5 SWOT Analysis Advanced Cell Technology, Inc. (USA)

1.3 California Stem Cell

1.3.1 Company Overview

1.3.2 Company Snapshot:

1.3.3 Key Strategies California Stem Cell

1.3.3.1 Primary Strategies: Approval

1.3.3.2 Secondary Strategies: Acquisition and clinical trials

1.3.4 SWOT Analysis of California Stem Cell

1.4 Osiris Therapeutics

1.4.1 Company Overview

1.4.2 Company Snapshot:

1.4.3 Key Financials Osiris Therapeutics

1.4.4 Key Strategies Osiris Therapeutics

1.4.4.1 Primary Strategies: Approval

1.4.4.2 Secondary strategies: Clinical Trials

1.4.5 SWOT analysis of Osiris therapeutics

1.5 NeoStem Inc.

1.5.1 Company Overview

1.5.2 Company Snapshot:

1.5.3 Key Financials NeoStem Inc.

1.5.4 Key Strategies NeoStem Inc.

1.5.4.1 Primary Strategies: Clinical Trials

1.5.4.2 Secondary Strategies: Collaboration

1.5.5 SWOT AnalysisofNeoStem Inc.

1.6 Geron Corporation

1.6.1 Company Overview

1.6.2 Company Snapshot:

1.6.3 Key Financials Geron Corporation

1.6.4 Key Strategies Geron Corporation

1.6.4.1 Primary Strategies: Clinical Trials and Investment

1.6.4.2 Secondary Strategies: Collaboration

1.6.5 SWOT Analysis of Geron Corporation

1.7 Opexa Therapeutics, Inc.

1.7.1 Company Overview

1.7.2 Company Snapshot:

1.7.3 Key Strategies Opexa Therapeutics, Inc.

1.7.3.1 Primary Strategies: Approval

1.7.3.2 Secondary Strategies: Agreement

1.7.4 SWOT Analysis of Opexa Therapeutics, Inc.

1.8 Athersys, Inc.

1.8.1 Company Overview

1.8.2 Company Snapshot:

1.8.3 Key Financials of Athersys, Inc.

1.8.4 Key Strategies Athersys, Inc.

1.8.4.1 Primary Strategies: Clinical Trials

1.8.4.2 Secondary Strategies: Collaboration

1.8.5 SWOT Analysis Athersys, Inc.

1.9 Pluristem Therapeutics Inc.

1.9.1 Company Overview

1.9.2 Company Snapshot:

1.9.3 Key FinancialsPluristem Therapeutics Inc.

1.9.4 Key Strategies Pluristem Therapeutics Inc.

1.9.4.1 Primary Strategies: Approval& Clearance

1.9.4.2 Secondary Strategies: Product Launch

1.9.5 SWOT Analysis of Pluristem Therapeutics Inc.

1.10 Mesoblast Limited

1.10.1 Company Overview

1.10.2 Company Snapshot:

1.10.3 Key Financials of Mesoblast Limited

1.10.4 Key Strategies of Mesoblast Limited

1.10.4.1 Primary Strategies: Acquisition

1.10.4.2 Secondary Strategies: Approval

1.10.5 SWOT Analysis ofMesoblast Limited

LIST OF TABLES AND FIGURES

TABLE 1 CYTORI THERAPEUTICS INC(USA) COMPANY SNAPSHOT

TABLE 2 ADVANCED CELL TECHNOLOGIES INC. COMPANY SNAPSHOT

TABLE 3 CALIFORNIA STEM CELL INC. COMPANY SNAPSHOT

TABLE 4 OSIRIS THERAPEUTICS COMPANY SNAPSHOT

TABLE 5 NEOSTEM INC COMPANY SNAPSHOT

TABLE 6 GERON CORPORATION COMPANY SNAPSHOT

TABLE 7 OPEXA THERAPEUTICS, INC. COMPANY SNAPSHOT

TABLE 8 ATHERSYS INC. COMPANY SNAPSHOT

TABLE 9 PLURISTEM THERAPEUTICS INC. COMPANY SNAPSHOT

TABLE 10 MESOBLAST LIMITED COMPANY SNAPSHOT